Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia Completed Phase 1 / 2 Trials for Imatinib (DB00619)

IndicationStatusPhase
DBCOND0029916 (Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00061945Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic LeukemiaTreatment
NCT00702403Nilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous LeukemiaTreatment